BEAT-SHOCK Registry

ConditionsCardiogenic Shock Myocardial Infarction (MI)Fulminant Myocarditis Acute Decompensated Heart Failure Severe Valvular Disease Post-cardiotomy Perioperative Cardiogenic Shock

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity Hospital, Basel, Switzerland

About this trial

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

Eligibility criteria

Qualifiers

Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay

Age ≥18 years

Provision of written ICF

Clinical diagnosis of cardiogenic shock.

Disqualifiers

Age <18 years

Refusal to provide informed consent by the patient or their legally authorized representative

Trial design

Treatments tested in this trial

no internvention

Treatment groups

No treatment groups listed

Sponsors and collaborators

University Hospital, Basel, Switzerland

Lead sponsor

Source ClinicalTrials.gov